13F HOLDINGS REPORT
Vida Ventures Advisors, LLC
Quarter ended Q1 2025 · Filed April 3, 2025 · Accession 0000950123-25-003299
Total Value
$13.6M
Positions
3
Other Managers
0
Confidential Omitted
No
Holdings (3)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Kyverna Therapeutics, Inc. | KYTX | 4,523,924 | $8.7M | 64.02% |
| 2 | Allogene Therapeutics, Inc. | ALLO | 1,798,163 | $2.6M | 19.25% |
| 3 | Kronos Bio, Inc. | 50107A104 | 2,765,314 | $2.3M | 16.73% |